Cart
sales@molnova.com
Ataractan
CAS No. 115-46-8
Ataractan( Azacyclonol )
Catalog No. M10544 CAS No. 115-46-8
Azacyclonol, also known as γ-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | 43 | In Stock |
|
Biological Information
-
Product NameAtaractan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzacyclonol, also known as γ-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
-
DescriptionAzacyclonol, also known as γ-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
-
In VitroAzacyclonol is formed from Terfenadine in rat liver.
-
In VivoAzacyclonol causes depressed activity in mice and rats.Azacyclonol antagonizes increased coordination activity in mice induced by pipradrol, amphetamine, morphine and cocaine and prolongs Hexobarbital hypnosis.
-
SynonymsAzacyclonol
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number115-46-8
-
Formula Weight267.36
-
Molecular FormulaC18H21NO
-
Purity>98% (HPLC)
-
SolubilityEthanol: 53 mg/mL (198.22 mM); Water: 2 mg/mL (7.48 mM); DMSO: 53 mg/mL (198.22 mM)
-
SMILESOC(C1=CC=CC=C1)(C2=CC=CC=C2)C3CCNCC3
-
Chemical Name4-Piperidinemethanol, alpha,alpha-diphenyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Raeissi SD, et al. Pharm Res, 1997, 14(8), 1019-1025.
molnova catalog
related products
-
SB1317
SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
-
Olanzapine
Olanzapine is an atypical antipsychotic, approved by the FDA in 1996.
-
SEP-363856 hydrochlo...
SEP-363856 hydrochloride is an agent of orally active and CNS active psychotropic with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects, has the potential to treatment of schizophrenia. SEP-856 (10μM) specifically inhibits α2A, α2B, D2, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7> 50% receptor.
